JP2023509187A5 - - Google Patents

Info

Publication number
JP2023509187A5
JP2023509187A5 JP2022541987A JP2022541987A JP2023509187A5 JP 2023509187 A5 JP2023509187 A5 JP 2023509187A5 JP 2022541987 A JP2022541987 A JP 2022541987A JP 2022541987 A JP2022541987 A JP 2022541987A JP 2023509187 A5 JP2023509187 A5 JP 2023509187A5
Authority
JP
Japan
Prior art keywords
amino acid
sequence shown
acid sequence
pharmaceutical composition
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022541987A
Other languages
English (en)
Japanese (ja)
Other versions
JP7820821B2 (ja
JP2023509187A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/050168 external-priority patent/WO2021140140A1/en
Publication of JP2023509187A publication Critical patent/JP2023509187A/ja
Publication of JP2023509187A5 publication Critical patent/JP2023509187A5/ja
Application granted granted Critical
Publication of JP7820821B2 publication Critical patent/JP7820821B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022541987A 2020-01-08 2021-01-07 アルツハイマー病の治療のための化合物及び方法 Active JP7820821B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20150738 2020-01-08
EP20150738.1 2020-01-08
PCT/EP2021/050168 WO2021140140A1 (en) 2020-01-08 2021-01-07 Compound and method for treatment of alzheimer's disease

Publications (3)

Publication Number Publication Date
JP2023509187A JP2023509187A (ja) 2023-03-07
JP2023509187A5 true JP2023509187A5 (cg-RX-API-DMAC7.html) 2024-01-30
JP7820821B2 JP7820821B2 (ja) 2026-02-26

Family

ID=69156193

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022541987A Active JP7820821B2 (ja) 2020-01-08 2021-01-07 アルツハイマー病の治療のための化合物及び方法

Country Status (5)

Country Link
US (1) US20230002458A1 (cg-RX-API-DMAC7.html)
EP (1) EP4087860B1 (cg-RX-API-DMAC7.html)
JP (1) JP7820821B2 (cg-RX-API-DMAC7.html)
CN (1) CN115943153A (cg-RX-API-DMAC7.html)
WO (1) WO2021140140A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024079221A1 (en) 2022-10-12 2024-04-18 Alphabeta Ab The bri2 brichos domain for delivery of proteins into cns neurons
WO2025078660A1 (en) 2023-10-11 2025-04-17 Alphabeta Ab The bri2 brichos domain for treatment of parkinson´s disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058353A1 (en) * 1998-12-10 2000-10-05 Shanghai Second Medical University Npcahh01: human transmembrane protein e3-16 gene
WO2006138355A2 (en) * 2005-06-14 2006-12-28 Albert Einstein College Of Medicine Of Yeshiva University Effect of bri proteins on abeta production
AU2010356144B2 (en) 2010-06-24 2015-06-04 Alphabeta Ab Compound and method for treatment of Alzheimer's disease and familial dementia
WO2012138284A1 (en) 2011-04-05 2012-10-11 Alphabeta Ab Amyloidosis target useful in methods of treatment and for screening of compounds

Similar Documents

Publication Publication Date Title
JP2023506765A5 (cg-RX-API-DMAC7.html)
CN102224168B (zh) 用于生产抗淀粉状蛋白β肽抗体的含有D-肽的组合物
JPWO2019156137A5 (cg-RX-API-DMAC7.html)
CA2529179A1 (en) Recombinant adeno-associated virus vector for treatment of alzheimer disease
JP2006516116A5 (cg-RX-API-DMAC7.html)
TW201629085A (zh) 芋螺毒素（ｃｏｎｏｔｏｘｉｎ）肽之修飾及用途
JP2023509187A5 (cg-RX-API-DMAC7.html)
JP2002206000A5 (cg-RX-API-DMAC7.html)
JP2009525323A (ja) 神経変性疾患の処置の為にｔｌｒ３アゴニストを使用する方法
CN102099372A (zh) 抗淀粉样蛋白免疫原性组合物、方法和应用
JP2023535121A5 (cg-RX-API-DMAC7.html)
JP2006502702A5 (cg-RX-API-DMAC7.html)
JP2022509445A5 (cg-RX-API-DMAC7.html)
JP2007535910A5 (cg-RX-API-DMAC7.html)
JP2020535161A5 (cg-RX-API-DMAC7.html)
RU2019136495A (ru) C-концевые фрагменты cdnf и маnf, фармацевтические композиции, содержащие указанные фрагменты, и применения указанных фрагментов и композиций
JP2023514659A5 (cg-RX-API-DMAC7.html)
JP7428404B2 (ja) Ｇｓｘ１を使用した脊髄損傷（ｓｃｉ）および脳損傷の処置
JP2024525213A5 (cg-RX-API-DMAC7.html)
US20180170983A1 (en) New Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Mild Cognitive Impairment
RU2010141916A (ru) Растворимый мутант рецептора фактора некроза опухоли
JP2013535965A5 (cg-RX-API-DMAC7.html)
JP2022530068A5 (cg-RX-API-DMAC7.html)
JP2009517009A5 (cg-RX-API-DMAC7.html)
CN101300031A (zh) 用sdf-1治疗和/或预防神经疾病